Differential Diagnosis of Uncommon Prostate Diseases: Combining MpMRI and Clinical Information

Overview

Journal Insights Imaging

Publisher Springer

Specialty Radiology

Date 2021 Jun 16

PMID 34132898

Citations 16

Authors

Chao Han

Lina Zhu

Xiang Liu

Shuai Ma

Yi Liu

Xiaoying Wang

Affiliations

Soon will be listed here.

Abstract

The differential diagnosis of abnormalities in the prostate is broad, covering common (acinar adenocarcinoma, benign prostatic hyperplasia, chronic prostatitis, hemorrhage, cysts, calcifications, atrophy and fibrosis) and less common conditions (tumors other than acinar adenocarcinoma, granulomatous prostatitis containing tuberculosis, abscesses and other conditions, and idiopathic disorders such as amyloidosis and exophytic benign prostatic hyperplasia). Recent advances in magnetic resonance imaging (MRI) of the prostate gland and imaging guidelines, such as the Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1), have dramatically improved the ability to distinguish common abnormalities, especially the ability to detect clinically significant prostate cancer (csPCa). Overlap can exist in the clinical history and imaging features associated with various common/uncommon prostate abnormalities, and biopsy is often required but is invasive. Prostate abnormalities can be divided into two categories: category 1, diseases for which PI-RADS scores are suitable for use, and category 2, diseases for which PI-RADS scores are unsuitable for use. Radiologists must have an intimate knowledge of other diseases, especially uncommon conditions. Past relevant history, symptoms, age, serum prostate-specific antigen (PSA) levels, MRI manifestations, and the applicability of the PI-RADS assessment should be considered when diagnosing prostate abnormalities.

Citing Articles

Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma - Anatomical Variations, Mimickers, and Post-Intervention Changes.

Yilmaz E, Esengur O, Gelikman D, Turkbey B Semin Ultrasound CT MR. 2024; 46(1):2-30.

PMID: 39580037 PMC: 11741936. DOI: 10.1053/j.sult.2024.11.001.

Fucoidan Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Rats.

Shanmugasundaram D, Dwan C, Wimmer B, Srivastava S Res Rep Urol. 2024; 16:283-297.

PMID: 39498260 PMC: 11532999. DOI: 10.2147/RRU.S478740.

Magnetic resonance imaging presentation of prostatic stromal sarcoma.

Huong N, Hang D, Ngoc Duong V, Anh N, Hung N, Cong B Radiol Case Rep. 2024; 19(10):4457-4463.

PMID: 39185438 PMC: 11342799. DOI: 10.1016/j.radcr.2024.07.022.

Primary Paraganglioma of the Prostate: A Systematic Review of the Literature for A Rare Entity.

Giannakodimos I, Ziogou A, Giannakodimos A, Mitakidi E, Tzelepis K, Fragkiadis E Rev Recent Clin Trials. 2024; 19(3):189-195.

PMID: 38549519 DOI: 10.2174/0115748871293735240209052044.

Exophytic benign prostatic hyperplasia presenting as a polycystic pelvic mass.

Xu S, Guo T, Zhang J, Zhang J, Zhang Z, Huang Y Urol Case Rep. 2023; 51:102582.

PMID: 37869527 PMC: 10587704. DOI: 10.1016/j.eucr.2023.102582.

References

Oberlin D, Casalino D, Miller F, Meeks J . Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol (NY). 2016; 42(4):1255-1258. DOI: 10.1007/s00261-016-0975-5. View

Chun C, Jung J, Baik J, Jee W, Kim S, Shin S . Detection of soft-tissue abscess: Comparison of diffusion-weighted imaging to contrast-enhanced MRI. J Magn Reson Imaging. 2017; 47(1):60-68. DOI: 10.1002/jmri.25743. View

De Gobbi A, Morlacco A, Valotto C, Vianello F, Zattoni F . An unusual cystic presentation of ductal carcinoma of the prostate. Urologia. 2016; 83(4):211-213. DOI: 10.5301/uro.5000157. View

Oyen R, Van de Voorde W, Van Poppel H, Brys P, Ameye F, Franssens Y . Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland. Radiology. 1993; 189(3):707-11. DOI: 10.1148/radiology.189.3.7694310. View

Gaudin P, Rosai J, Epstein J . Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases. Am J Surg Pathol. 1998; 22(2):148-62. DOI: 10.1097/00000478-199802000-00002. View

Ronchi A, Cozzolino I, Marino F, Accardo M, Montella M, Panarese I . Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features. Ann Diagn Pathol. 2018; 34:142-150. DOI: 10.1016/j.anndiagpath.2018.01.004. View

Tang J, Yang J, Zhang Y, Liu X, Zhang L, Wang Z . Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study. BJU Int. 2007; 100(5):1091-6. DOI: 10.1111/j.1464-410X.2007.07081.x. View

Tanaka Y, Nakamoto A, Inada Y, Narumi Y, Hirose Y, Azuma H . A case of malignant solitary fibrous tumor of the prostatic urethra. BJR Case Rep. 2019; 4(4):20180034. PMC: 6438398. DOI: 10.1259/bjrcr.20180034. View

Oguro S, Tanimoto A, Jinzaki M, Akita H, Yashiro H, Okuda S . Imaging findings of solitary fibrous tumor of the prostate: a case report. Magn Reson Imaging. 2006; 24(5):673-5. DOI: 10.1016/j.mri.2005.12.018. View

10.

Suzuki T, Takeuchi M, Naiki T, Kawai N, Kohri K, Hara M . MRI findings of granulomatous prostatitis developing after intravesical Bacillus Calmette-Guérin therapy. Clin Radiol. 2013; 68(6):595-9. DOI: 10.1016/j.crad.2012.12.005. View

11.

Li Y, Mongan J, Behr S, Sud S, Coakley F, Simko J . Beyond Prostate Adenocarcinoma: Expanding the Differential Diagnosis in Prostate Pathologic Conditions. Radiographics. 2016; 36(4):1055-75. DOI: 10.1148/rg.2016150226. View

12.

Daigeler A, Lehnhardt M, Langer S, Steinstraesser L, Steinau H, Mentzel T . Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues. BMC Surg. 2006; 6:10. PMC: 1523192. DOI: 10.1186/1471-2482-6-10. View

13.

Currin S, Flood T, Krishna S, Ansari A, McInnes M, Schieda N . Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers. J Magn Reson Imaging. 2018; 50(1):279-287. DOI: 10.1002/jmri.26594. View

14.

Crocetto F, Barone B, De Luca L, Creta M . Granulomatous prostatitis: a challenging differential diagnosis to take into consideration. Future Oncol. 2020; 16(13):805-806. DOI: 10.2217/fon-2020-0185. View

15.

Kitzing Y, Prando A, Varol C, Karczmar G, Maclean F, Oto A . Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation. Radiographics. 2015; 36(1):162-75. PMC: 5496681. DOI: 10.1148/rg.2016150030. View

16.

Chu L, Ross H, Lotan T, Macura K . Prostatic stromal neoplasms: differential diagnosis of cystic and solid prostatic and periprostatic masses. AJR Am J Roentgenol. 2013; 200(6):W571-80. DOI: 10.2214/AJR.12.9741. View

17.

Abdulsalam A, Abdulsalam M . An unusual case of prostate tuberculosis: a case report. Int Med Case Rep J. 2015; 8:99-102. PMC: 4427073. DOI: 10.2147/IMCRJ.S83351. View

18.

Tsuzuki T . Intraductal carcinoma of the prostate: a comprehensive and updated review. Int J Urol. 2014; 22(2):140-5. DOI: 10.1111/iju.12657. View

19.

Olgun D, Onal B, Mihmanli I, Kantarci F, Durak H, Demir H . Giant multilocular cystadenoma of the prostate: a rare cause of huge cystic pelvic mass. Korean J Urol. 2012; 53(3):209-13. PMC: 3312072. DOI: 10.4111/kju.2012.53.3.209. View

20.

Schieda N, Coffey N, Gulavita P, Al-Dandan O, Shabana W, Flood T . Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI). Eur Radiol. 2014; 24(6):1349-56. DOI: 10.1007/s00330-014-3150-9. View